Introducing CiteLines’ SiteTrove Diversity Module: Enhancing Clinical Trials with Robust Investigator and Site Intelligence, Backed by Patient Demographics
Introducing Citeline’s Sitetrove Diversity Module: Enhancing Clinical Trials with Robust Investigator and Site Intelligence, Backed by Patient Demographics NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) — With new Food and Drug Administration (FDA) guidance, study sponsors are no longer viewing clinical trial diversity as “nice to have” but as a “must have.” Citeline’s new Sitetrove…